Navigation Links
National Coalition Continues Fight to Stop the Express Scripts/Medco Merger in Nation's Capitol
Date:12/1/2011

WASHINGTON, Dec. 1, 2011 /PRNewswire/ -- Just days before the Senate Judiciary Committee's Subcommittee on Antitrust, Competition Policy and Consumer Rights hearing to investigate the proposed merger between Express Scripts Inc. and Medco Health Solutions consumers, small business owners and community pharmacists with Preserve Community Pharmacy Access NOW! (PCPAN) traveled to Washington, D.C. today, to oppose the deal.  While in town, PCPAN members and leadership met with elected representatives on Capitol Hill and others.

The coalition expressed concerns that an approved merger would combine two of the nation's three largest pharmacy benefit managers (PBMs), giving the consolidated mega-PBM the unfettered ability to increase prices and reduce access to pharmacy services.  There is widespread concern from elected officials including attorneys general in dozens of states, pharmacy service providers, consumer advocates, patient advocates and others.  All have expressed concerns that approving this merger would result in increased costs for lesser quality health care.

"Approving this merger would give the consolidated PBM the unchecked ability to steer consumers away from community pharmacies until, eventually, they no longer have a choice," said Eva M. Clayton, chair of Preserve Community Pharmacy Access NOW! (PCPAN).  "In many areas, pharmacists are the most accessible health care professional, providing important services at affordable prices and at convenient times and locations, and fazing them out of the health care system wouldn't just be inconvenient, it would be disastrous – particularly for those in underserved communities.  We need to make sure that this doesn't happen and oppose the merger between Express Scripts Inc. and Medco Health Solutions."

PBMs are the largely unregulated drug middlemen that manage prescription drug benefit programs for employers, unions, health plans and others.  Today, PBMs control the drug benefits of more than 200 million patients nationwide.  This number includes a diverse group of Americans such as Medicare Part D beneficiaries, servicemen and veterans who are TRICARE beneficiaries, and more.

"PBMs were created to help plan sponsors and patients save money – but it would seem that, over time, they have become more focused on increasing their bottom line than fulfilling this objective," said Dennis Archer, the chief legal counsel for Preserve Community Pharmacy Access NOW! (PCPAN).  "I do not believe that allowing a merger that would give an even bigger PBM unprecedented power and control over the market and the prescription drug plans of millions of Americans would be in the best interest of anyone but Express Scripts and Medco, and I hope that the merger is challenged by the Federal Trade Commission."

Last July, Express Scripts Inc. and Medco Health Solutions Inc, two of the nation's largest PBMs, announced a merger agreement that could go into effect as soon as early 2012.  The merger has been investigated by a House antitrust committee and will be investigated by the Senate Judiciary Committee's Subcommittee on Antitrust, Competition Policy and Consumer Rights in December.  The Federal Trade Commission (FTC) will ultimately determine whether or not the deal will move forward.  PCPAN members hope that Members of Congress will stand up for patient care and oppose the merger.

Preserve Community Pharmacy Access NOW! is a coalition of consumers, businesses and community-based pharmacists from across the country that have come together for the purpose of opposing the planned merger between Express Scripts Inc. and Medco Health Solutions Inc.  PCPAN is a project of Pharmacy Choice and Access Now.


'/>"/>
SOURCE Preserve Community Pharmacy Access NOW! (PCPAN)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tom Hall Named National Sales and Marketing Director for VR Laboratories
2. Instrumentation Laboratory Introduces Automated HemosIL VWF Ristocetin Cofactor Activity Assay in Europe and International Regions
3. Athens, Ohio and the National League of Cities Bring Free Prescription Discount Card Program to Residents
4. Canadian Patent Issued to Medizone International for AsepticSure™ Disinfection Technology
5. Leading Executives Once Again Meet at GDS International’s Next Generation Pharmaceutical Manufacturing Europe Summit to Discuss Key Objectives For The Industry
6. Leading Chemical Weapons Preparedness Companies Announce Partnership to Deploy Break-through Diagnostic Test Internationally
7. The Appellate Division of State Supreme Court has Upheld a Landmark 2010 Products Liability Verdict Which Found Cybex International Responsible for Catastrophic Injuries Suffered by a Cheektowaga Woman
8. U.S. Biomedical Leaders Present Leaders on Capitol Hill with New National Strategy for Innovation
9. International Isotopes Inc. Announces Third Quarter and Nine Months 2011 Financial Results
10. Varian Medical Systems to Highlight the Latest Digital Detectors and X-ray Tubes at the MEDICA 2011 International Trade Fair
11. The National Association of Drug Diversion Investigators, Inc. (NADDI) Host 22nd Annual Educational Training Conference at the Hyatt Regency Riverfront in Jacksonville, Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
(Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica ... in thought leadership , media relations, social media, content marketing and SEO, ... be powered through Act-On, an intuitive marketing automation platform. , Rosica will now ...
(Date:2/23/2017)... ... 23, 2017 , ... On February 22, 2017 the U.S. ... to withdraw previous guidance issued by the Obama Administration requiring schools to treat ... 2016 by the Obama Administration came in response to a growing number of ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The American Cleft ... ACPA’s 74th Annual Meeting. KLS is a longtime supporter of the event. , ... exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
Breaking Medicine News(10 mins):